𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study

✍ Scribed by Gianni Biancofiore; Maria L. Bindi; Rubia Baldassarri; Anna Maria Romanelli; Gabriele Catalano; Franco Filipponi; Antonio Vagelli; Franco Mosca


Book ID
110916093
Publisher
Springer
Year
2002
Tongue
English
Weight
609 KB
Volume
15
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Antifungal prophylaxis in liver transpla
✍ Gregory A. Eschenauer; Simon W. Lam; Peggy L. Carver πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 169 KB

Although the overall incidence of fungal infections in liver transplant recipients has declined, these infections still contribute significantly to the morbidity and mortality of patients with risk factors for infection. Although antifungal prophylaxis has been widely studied and practiced, no conse

Erratum: Antifungal prophylaxis in liver
✍ Gregory A. Eschenauer; Simon W. Lam; Peggy L. Carver πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 120 KB

UNOS status 4 (life support in ICU) 146 6.3 (2.4-16.7) George 1997 ( 14 ) Donor CMV ΓΎ/recipient -146 4.8 (2.0-11.8) George 1997 ( 14 ) UNOS class I (life support in ICU) 172 3.5 (1.7-7.0) Winston 1999 ( 23 ) Fungal colonization at baseline 172 2.3 (1.2-4.3) Winston 1999 ( 23 ) Pretransplant SCr 3 mg

Prophylactic fluconazole in liver transp
✍ Robin Patel πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 64 KB

Background: Among persons who receive solid organ transplants, liver transplant recipients have the highest incidence of invasive fungal infection; however, no antifungal prophylaxis has been proven to be effective. ## Objective : To evaluate the efficacy and safety of prophylactic fluconazole in